ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Doctors Are Doing More Cancer Screening, ACS Survey Finds

March 30, 1990

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

NIC Grants Appeals Process Explained

April 19, 1985

In Brief: Long Island In, Seattle Out Of Community Based Cancer Program; Six Still In Running

December 10, 1976